Cite
Momtazmanesh S, Rayzan E, Zoghi S, et al. Novel Variants of DOCK8 Deficiency in a Case Series of Iranian Patients. Endocr Metab Immune Disord Drug Targets. 2021;doi: 10.2174/1871530321666210226143912.
Momtazmanesh, S., Rayzan, E., Zoghi, S., Shahkarami, S., Molatefi, R., Mohammadzadeh, I., Ghaffari, J., Mahmoudi, H., Dmytrus, J., Segarra-Roca, A., Somekh, I., Witzel, M., Hauck, F., Boztug, K., Klein, C., & Rezaei, N. (2021). Novel Variants of DOCK8 Deficiency in a Case Series of Iranian Patients. Endocrine, metabolic & immune disorders drug targets, . https://doi.org/10.2174/1871530321666210226143912
Momtazmanesh, Sara, et al. "Novel Variants of DOCK8 Deficiency in a Case Series of Iranian Patients." Endocrine, metabolic & immune disorders drug targets vol. (2021). doi: https://doi.org/10.2174/1871530321666210226143912
Momtazmanesh S, Rayzan E, Zoghi S, Shahkarami S, Molatefi R, Mohammadzadeh I, Ghaffari J, Mahmoudi H, Dmytrus J, Segarra-Roca A, Somekh I, Witzel M, Hauck F, Boztug K, Klein C, Rezaei N. Novel Variants of DOCK8 Deficiency in a Case Series of Iranian Patients. Endocr Metab Immune Disord Drug Targets. 2021 Feb 26; doi: 10.2174/1871530321666210226143912. Epub 2021 Feb 26. PMID: 33634762.
Copy
Download .nbib